Economy

Analysts Recommendations Valeant Pharmaceuticals International, Inc. (VRX)

Now have a look at past performance (weekly performance to year to date performance) how Valeant Pharmaceuticals International, Inc. Scotiabank decreased their price objective on Valeant Pharmaceuticals International from $15.00 to $12.00 and set a "sector perform" rating for the company in a report on Wednesday, April 26th. Hedge funds and other institutional investors own 50.45% of the company's stock. Live Your Vision Limited Liability Com has 0.01% invested in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).

05/15/2017 - Valeant Pharmaceuticals International, Inc. had its "hold" rating reiterated by analysts at Barclays. Oxford Asset Management purchased a new position in shares of Valeant Pharmaceuticals International during the fourth quarter worth $2,403,000.

The Stock traded with an actual day volume of 19.29 Million and average volume of 23.51 Million respectively. They now have a $10.00 price target on the specialty pharmaceutical company's stock. On December 15 the stock rating was downgraded from "Neutral" to "Equal-Weight" and a price target of $17.00 was set in a statement from Morgan Stanley. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Hsbc Holdg Public Ltd Com holds 0.01% in Valeant Pharmaceuticals Intl Inc (TSE:VRX) or 312,267 shares. World Asset Management Inc now owns 21,502 shares of the specialty pharmaceutical company's stock valued at $237,000 after buying an additional 328 shares during the last quarter. Alyeska Invest Grp Lp owns 1.51M shares for 0.2% of their portfolio. The company's market capitalization is $5.65 billion.

Valeant Pharmaceuticals International, Inc. has a 50 day moving average of 13.59 and a 200 day moving average of 12.98. For the past 5 years, the stock's EPS growth has been almost -17.00%.

Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) last posted its earnings results on Tuesday, May 9th.

05/09/2017 - Valeant Pharmaceuticals International, Inc. had its "neutral" rating reiterated by analysts at BTIG Research.

Several other equities research analysts also recently issued reports on VRX. Gruss & Co. Inc. acquired a new position in Valeant Pharmaceuticals International during the first quarter worth about $104,000. The specialty pharmaceutical company reported $2.80 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.87 by $1.93. The business had revenue of $2.11 billion for the quarter, compared to analyst estimates of $2.17 billion. Valeant Pharmaceuticals International had 35 analyst reports since October 20, 2015 according to SRatingsIntel.

WARNING: "Valeant Pharmaceuticals International, Inc".

In terms of Valeant Pharmaceuticals International, Inc. If you are accessing this report on another publication, it was stolen and reposted in violation of US & global copyright laws. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/07/10/valeant-pharmaceuticals-international-inc-vrx-stock-rating-lowered-by-bidaskclub-updated-updated.html. During the same quarter in the previous year, the firm posted ($1.08) earnings per share.

In other Valeant Pharmaceuticals International news, Director Schutter Richard U. De acquired 20,000 shares of the business's stock in a transaction on Thursday, May 11th. Gulf International Bank UK Ltd increased its position in shares of Valeant Pharmaceuticals International by 1.1% in the first quarter. The stock was purchased at an average cost of C$13.90 per share, for a total transaction of C$278,000.00. (VRX) have 351.90 million outstanding shares now held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Private Advisor Group LLC increased its position in shares of Valeant Pharmaceuticals International by 23.2% in the fourth quarter. The Lagoda Investment Management Lp holds 36,119 shares with $5.94M value, down from 53,579 last quarter. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined 48.51% since July 10, 2016 and is downtrending. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women.



Like this

Latest


10 July 2017
Lena Dunham is selling her entire wardrobe for a very important cause
Dunham, a frequent critic of Trump, said, "If you had told me six years ago that we would be in the place we are now, I would have said that you were insane ".

10 July 2017
How to get free Chick-fil-A Tuesday in DFW
But, should you find yourself wanting to go all out and dress up in a full cow costume, more power to you. Last year, more than 1.6 million chicken eaters donned cow spots and udders for Cow Appreciation Day .

10 July 2017
ValuEngine Upgrades Tahoe Resources, Inc. (TAHO) to "Buy"
The Average Volume of the company is 3.39 Million, while the Volume of the company in the last trading session was 8.64 Billion. The fund owned 13,500 shares of the basic materials company's stock after selling 12,100 shares during the period.

10 July 2017
Malayalam actress molestation case: Actor Dileep arrested on conspiracy charges
While Suni and his accomplices were arrested within a week of the kidnapping, police stumbled upon the conspiracy angle last week. The actress was kidnapped on February 17, and later the news went viral with the photographs which were taken by the kidnappers.

10 July 2017
Governance deficit in many states says, NITI Aayog CEO Amitabh Kant
The PM emphasised the importance of preserving institutional memory, NITI Aayog Vice Chairman Arvind Panagariya said. He gave the example of monthly PRAGATI meetings, which had given a decisive push to many long-pending projects.

10 July 2017
'The Walking Dead' Voice Actor Dies in Tragic Skydiving Accident
Schell's agent, Jenny Josby , spoke to KHOU 11 News shortly after the actor's passing to rave about her late client. He was one of eight people who participated in the formation skydive on Saturday.

10 July 2017
Sourav Ganguly says Virat Kohli needs to understand how coaches operate
Further elaborating the decision, Ganguly said that he, along with Sachin Tendulkar and V.V.S. So we understand where it goes. "We want the best possible thing".

10 July 2017
First Liverpool, now Chelsea: Roma play hardball again
Gazzetta dello Sport have a small Antonio Rudiger to Chelsea update on Monday, rubbishing some claims of a move to Manchester. Juventus full-back Sandro will be the costliest acquisition of the trio, with his fee potentially rising to £60 million.

10 July 2017
Core Laboratories NV (NYSE:CLB) Receives $122.78 Average Price Target from Analysts
Sei Invests has 0% invested in Chimerix Inc (NASDAQ:CMRX) for 958 shares. 400,000 were accumulated by Prudential Public Ltd Co. BidaskClub upgraded shares of Core Laboratories N.V. from a "sell" rating to a "hold" rating in a research note on Wednesday.

10 July 2017
Anurag Thakur told to offer fresh unconditional apology
When asked if the BCCI wanted this recommendation to be removed entirely, Choudhary only said, "it needs a review". The meeting was attended by chairman Rajiv Shukla, Naba Bhattacharjee, Jay Shah, Anirudh Chaudhry and Choudhary.



Recommended